Company intelligence / Profile preview

LSWorks

New York City, New York, United Stateslsworks.org ↗

Ownership: Private
Development stage: Other

Overview

LSWorks is an active venture creation firm that partners with scientists to build new life science companies. It provides hands-on entrepreneurial support, seed capital ($100k–$250k), and management expertise to commercialize novel biotech, medical device, and life science service innovations. The company has played key roles in launching successful ventures such as Oncoceutics (oncology small molecules) and ImmunoGenes AG (antibody production technology), often guiding them from concept through acquisition or commercialization.

Therapeutic areas: OncologyOther
Modalities: Small moleculeAntibody
Industry: Investors

Partnerships

Pennsylvania State University (technology licensing partner via Oncoceutics)Major U.S. and global pharmaceutical firms (via outlicensing/licensing activities of portfolio companies)

Beyond the preview

Go deeper on LSWorks.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LSWorks.

Explore the full profile